We describe 2 challenging cases of cardiac transthyretin amyloidosis initially treated as cardiac amyloidosis light chain in the setting of active myeloma. Endomyocardial biopsy with mass spectrometry was essential to confirm the appropriate diagnosis to direct the treatment.
Keywords: cardiac amyloidosis; endomyocardial biopsy; genetic testing; mass spectrometry.
Published by Elsevier Inc.